Influence of CYP2B6 and CYP3A4 polymorphisms on the virologic and immunologic responses of patients treated with efavirenz-containing regimen.
Kassogue Y, Diakite B, Maiga M, Kassogue O, Konate I, Tamboura K, Diarra F, Diarra Z, Sawadogo MK, Goita Y, Sissoko SB, Sissoko AS, Guirou N, Dehbi H, Nadifi S, Bah S, Traore CB, Kamate B, Dao S, Dolo G.
Kassogue Y, et al. Among authors: sawadogo mk.
Pharmacogenet Genomics. 2022 Aug 1;32(6):219-225. doi: 10.1097/FPC.0000000000000477. Epub 2022 Jun 22.
Pharmacogenet Genomics. 2022.
PMID: 35852913
Free PMC article.